Search Results 231-240 of 5977 for albumin

1. A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies - Mayo Clinic

   Albumin ≥ 3.0 g/dL;; Creatinine clearance or eGFR ≥ 30 mL/min as estimated by the Cockcroft-Gault equation;; AST/ALT ≤ 2 x ULN. If documented liver ...

2. Study of HPN536 in Patients with Advanced Cancers Associated With Mesothelin Expression - Mayo Clinic

   Serum albumin ≥ 30 mg/mL. Exclusion Criteria: Previously treated or current brain metastases. Note: Patients with previously treated brain metastases may ...

3. Low-Dose or High-Dose Lenalidomide in Treating Children with Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma - Mayo Clinic

   Serum albumin ≥ 2 g/dL; No evidence of dyspnea at rest and a pulse oximetry > 94% if there is clinical indication for determination; Patients must be able to ...

4. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) - Mayo Clinic

   The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy ...

5. A Study to Evaluate the Safety, Tolerability, Drug/Body Interactions, and Activity of Oradoxel for Patients with Advanced Malignancies - Mayo Clinic

   ... albumin. Adequate renal function as demonstrated by serum creatinine ≤ 1.5 x ULN or creatinine clearance>60 mL/min as calculated by the Cockroft and Gault ...

6. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

   Serum albumin < 3.5 g/ dL;; Platelet count < 100 × 103/μL;; International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting ...

7. Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer - Mayo Clinic

   ... albumin > 3 g/dL). Docetaxel will only be option in TPC arm for subjects with a total bilirubin ≤ 1 x IULN, and an AST and/or ALT ≤ 1.5 x IULN if alkaline ...

8. FT819 in Subjects With B-cell Malignancies - Mayo Clinic

   Known allergy to albumin (human) or DMSO. Eligibility last updated 1/7/22. Questions regarding updates should be directed to the study team contact ...

9. Drugs and Supplements that Start with V - Mayo Clinic

   Albumin, iodinated i-131 (intravenous route) · Von willebrand factor recombinant (intravenous route). Vonjo. Also known as. Pacritinib (oral route) · Vonoprazan ...

10. A Study to Evaluate Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell Lung Cancer - Mayo Clinic

    ... albumin ≥ 3.0 g/dL;; Hepatic function for subjects with liver metastases: bilirubin ≤ 1.5 × ULN, AST, ALT, and GGT ≤ 5.0 × ULN, and albumin ≥ 3.0 g/dL.